Lantheus Holdings (LNTH) Other Non-Current Liabilities (2013 - 2026)
Lantheus Holdings (LNTH) reported Other Non-Current Liabilities of $139000.0 for Q1 2026, down 99.76% year-over-year from $58.2 million in Q1 2025, and up 0.72% quarter-over-quarter from $138000.0 in Q4 2025.
Lantheus Holdings (LNTH) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 14 years of Other Non-Current Liabilities data on file, last reported at $139000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $139000.0, down 99.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $139000.0 (down 99.76% YoY), and the FY2025 annual result was $138000.0, down 99.78% from the prior year.
- Other Non-Current Liabilities improved to $139000.0 in Q1 2026 per LNTH's latest filing, from $138000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $116.2 million in Q3 2025 and troughed at $136000.0 in Q2 2025.
- A 5-year average of $33.7 million and a median of $22.9 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities jumped 2379.72% in 2024, then plunged 99.78% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $22.5 million in 2022, then rose by 1.65% to $22.9 million in 2023, then soared by 175.7% to $63.2 million in 2024, then sank by 99.78% to $138000.0 in 2025, then advanced by 0.72% to $139000.0 in 2026.
- Business Quant data shows LNTH's Other Non-Current Liabilities at $139000.0 in Q1 2026, $138000.0 in Q4 2025, and $116.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139,000.00 |
| Dec 31, 2025 | 138,000.00 |
| Sep 30, 2025 | 116.18 Mn |
| Jun 30, 2025 | 136,000.00 |
| Mar 31, 2025 | 58.19 Mn |
| Dec 31, 2024 | 63.18 Mn |
| Sep 30, 2024 | 61.99 Mn |
| Jun 30, 2024 | 25.10 Mn |
| Mar 31, 2024 | 63.11 Mn |
| Dec 31, 2023 | 22.92 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 22.73 Mn |
| Mar 31, 2023 | 46.21 Mn |
| Dec 31, 2022 | 22.54 Mn |
| Sep 30, 2022 | 23.36 Mn |
| Jun 30, 2022 | 22.20 Mn |
| Mar 31, 2022 | 21.51 Mn |
| Dec 31, 2021 | 20.83 Mn |
| Sep 30, 2021 | 89.64 Mn |
| Jun 30, 2021 | 14.80 Mn |